Anika Therapeutics
ANIK
ANIK
166 hedge funds and large institutions have $726M invested in Anika Therapeutics in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+7
Holders Change %
+4.4%
% of All Funds
4.14%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
61
Reduced
49
Closed
14
Calls
$2.67M
Puts
$1.7M
Net Calls
+$970K
Net Calls Change
-$2M
Top Buyers
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$13.5M |
| 2 |
Goldman Sachs
New York
|
+$7.42M |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
+$6.16M |
| 4 |
Bank of New York Mellon
New York
|
+$2.96M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.44M |
Top Sellers
| 1 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$11.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$8.46M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$5.79M |
| 4 |
Two Sigma Investments
New York
|
-$3.3M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$2.25M |
